Retrospective Analysis of PET Brain Imaging in Chronic Cancer Pain

Completed

• Conditions: Cancer Pain

• Registration Number: NCT04537845
• Lead Sponsor: National Taiwan University Hospital

Brief Summary

Cancer pain deteriorated in quality of life and related with numerous psychosocial problems. Over the one third of cancer patient suffered from moderate to severe cancer pain, even under adequate pain management.

The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images can provide quantitative results in clinical oncology. As a functional neuroimaging, the PET evidently provided anatomical activated regions, size, and spatial extent information. In this retrospective study, we use FDG-PET to investigate changes concerning the glucose metabolism in the brain with or without cancer pain.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-02
• Primary Completion: 2020-08-08
• Study Completion: 2020-08-08
• Study First Submitted: 2020-08-30
• Study First Submitted QC: 2020-08-30
• Study First Posted: 2020-09-03
• Status Verified: 2021-08
• Last Update Submitted: 2022-09-19
• Last Update Posted: 2022-09-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 119

Inclusion Criteria

• cancer patient

Read More

Exclusion Criteria

• no brain metastasis

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Find the location of brain metabolic changes, pain scale	12 months	This retrospective analysis only compare image and clinical record including pain scale

Trial Locations

Locations (1)

National Taiwan University Hosipital; 🇨🇳 Taipei City, Taiwan